Skip to main content

Table 2 Induction of complement-mediated lysis

From: Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors

 

monkey

%lysis day of challenge

%lysis 2 wpc

viral load 2 wpca

%lysis 28 wpc

viral load 28 wpca

group 1

12127

16

18

2.7 × 103

49

1.8 × 103

 

12128

26

18

4.7 × 104

41

6.6 × 103

 

12131

18

11

1.3 × 104

51

3.1 × 103

 

12137

20

46

6.6 × 104

53

20

group 2

12133

25

96

3.4 × 104

35

1.9 × 103

 

12136

25

40

6.9 × 104

66

1.1 × 104

 

12142

35

23

1.2 × 103

58

2.1 × 104

 

12143

25

50

6.8 × 102

68

> 10

group 3

12132

23

48

1.9 × 104

81

1.8 × 105

 

12138

35

45

5.5 × 105

63

4.1 × 103

 

12139

20

51

2.4 × 105

66

2.4 × 104

 

12140

30

63

4.3 × 104

71

7.7 × 102

group 4

12129

< 10

12

9.0 × 105

71

1.2 × 105

 

12130

< 10

18

6.7 × 106

68

1.6 × 106

 

12134

< 10

28

2.1 × 106

81

1.4 × 104

 

12141

< 10

40

1.0 × 106

87

4.2 × 104

  1. aRNA copies/ml plasma